Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingfeng Shi

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Pathology|October 4, 2019
Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosisYingfeng Shi, Min Tao, Yi Wang, et al.
Cell Death & Disease|June 20, 2020
Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathyYingfeng Shi, Min Tao, Xiaoyan Ma, et al.
Oncotarget|November 16, 2017
Targeting Src attenuates peritoneal fibrosis and inhibits the epithelial to mesenchymal transitionJun Wang, Li Wang, Liuqing Xu, et al.
Journal of the American Society of Nephrology : JASN|December 19, 2015
Inhibition of EGF Receptor Blocks the Development and Progression of Peritoneal FibrosisLi Wang, Na Liu, Chongxiang Xiong, et al.
Frontiers in Immunology|March 21, 2022
Blockade of Autophagy Prevents the Progression of Hyperuricemic Nephropathy Through Inhibiting NLRP3 Inflammasome-Mediated PyroptosisYan Hu, Yingfeng Shi, Hui Chen, et al.
BMJ Open|March 4, 2019
Relationship between serum uric acid and clustering of cardiovascular disease risk factors and renal disorders among Shanghai population: a multicentre and cross-sectional studyMin Tao, Xiaoling Pi, Xiaoyan Ma, et al.
American Journal of Translational Research|April 12, 2021
Curcumin promotes the survival of ischemic random skin flaps via autophagyZhuolong Tu, Xiaoqi Jiang, Yuan Li, et al.
Frontiers in Pharmacology|September 9, 2021
Blockade of Autophagy Prevents the Development and Progression of Peritoneal FibrosisYingfeng Shi, Yan Hu, Yi Wang, et al.
Renal Failure|September 19, 2025
Roxadustat alleviates cisplatin-induced acute kidney injury by regulating fatty acid oxidation and mitochondrial functionXialin Li, Yan Hu, Jinqing Li, et al.
American Journal of Physiology. Renal Physiology|January 17, 2019
Blockade of ERK1/2 by U0126 alleviates uric acid-induced EMT and tubular cell injury in rats with hyperuricemic nephropathyMin Tao, Yingfeng Shi, Lunxian Tang, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Pathology|October 4, 2019
Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosisYingfeng Shi, Min Tao, Yi Wang, et al.
Cell Death & Disease|June 20, 2020
Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathyYingfeng Shi, Min Tao, Xiaoyan Ma, et al.
Oncotarget|November 16, 2017
Targeting Src attenuates peritoneal fibrosis and inhibits the epithelial to mesenchymal transitionJun Wang, Li Wang, Liuqing Xu, et al.
Journal of the American Society of Nephrology : JASN|December 19, 2015
Inhibition of EGF Receptor Blocks the Development and Progression of Peritoneal FibrosisLi Wang, Na Liu, Chongxiang Xiong, et al.
Frontiers in Immunology|March 21, 2022
Blockade of Autophagy Prevents the Progression of Hyperuricemic Nephropathy Through Inhibiting NLRP3 Inflammasome-Mediated PyroptosisYan Hu, Yingfeng Shi, Hui Chen, et al.
BMJ Open|March 4, 2019
Relationship between serum uric acid and clustering of cardiovascular disease risk factors and renal disorders among Shanghai population: a multicentre and cross-sectional studyMin Tao, Xiaoling Pi, Xiaoyan Ma, et al.
American Journal of Translational Research|April 12, 2021
Curcumin promotes the survival of ischemic random skin flaps via autophagyZhuolong Tu, Xiaoqi Jiang, Yuan Li, et al.
Frontiers in Pharmacology|September 9, 2021
Blockade of Autophagy Prevents the Development and Progression of Peritoneal FibrosisYingfeng Shi, Yan Hu, Yi Wang, et al.
Renal Failure|September 19, 2025
Roxadustat alleviates cisplatin-induced acute kidney injury by regulating fatty acid oxidation and mitochondrial functionXialin Li, Yan Hu, Jinqing Li, et al.
American Journal of Physiology. Renal Physiology|January 17, 2019
Blockade of ERK1/2 by U0126 alleviates uric acid-induced EMT and tubular cell injury in rats with hyperuricemic nephropathyMin Tao, Yingfeng Shi, Lunxian Tang, et al.
Pageof 6